Get a Sample Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-travel-vaccine-market
A biological preparation known as a vaccination offers active acquired protection to a specific infectious disease. A vaccination often comprises a substance that resembles a germ that causes a disease, this substance is frequently created from a bacteria's weaker or dead forms, its toxins, or one of its surface proteins.
Key Growth Drivers:
- Increase in cases of flu
The flu part for the most comprehensive travel vaccine business serving is estimated based on the target virus. That was largely attributable to the enormous number of cases of influenza that were accounted for throughout the forecast period and the segment will continue to control the market.
- Increase in costs for vaccination
Travel-related viruses like hepatitis, tetanus, Japanese encephalitis, meningitis, and yellow fever are becoming more widespread all over the world. This would significantly increase the costs associated with the development of more effective vaccinations, opening up new market opportunities for travel vaccines throughout the forecast period of 2022 to 2029.
- Rising number of vaccines
Global arrivals of foreign visitors surged from 1.0 billion in 2012 to about 1.4 billion in 2018. Many of these tourists travel from rich nations to places where endemic diseases are prevalent. The need for vaccines will rise as more individuals travel to nations where certain diseases are widespread.
The report outlines the involvement of key players, including:
GSK plc (U.K.), Sanofi (France), Merck KGaA (Germany), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Bavarian Nordic (Denmark), Janssen Pharmaceuticals Inc. (U.S.), CSL Limited (Australia), AstraZeneca (U.K.), Altimmune (U.K.), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Crucell (Netherlands)
Key Market Segmentation
Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others)
The Travel Vaccine market report includes the following countries in different regions:
The regions mentioned above encompass a comprehensive coverage of key markets, offering a global perspective on the market landscape. Here's an overview of the regions and the countries they include:
- North America: United States, Canada, and Mexico.
- Europe: Germany, France, United Kingdom, Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and other European countries.
- Asia-Pacific (APAC): China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and other Asia-Pacific countries.
- Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates (U.A.E), South Africa, Egypt, Israel, and other countries in the Middle East and Africa region.
- South America: Brazil, Argentina, and other countries in South America.
Know More about This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-travel-vaccine-market
Browse More Reports:
https://www.databridgemarketresearch.com/reports/global-icu-devices-market
https://www.databridgemarketresearch.com/reports/global-ultramicrotome-market
https://www.databridgemarketresearch.com/reports/global-cryochambers-market
https://www.databridgemarketresearch.com/reports/global-monoclonal-antibodies-market
https://www.databridgemarketresearch.com/reports/global-tularemia-therapeutics-market
https://www.databridgemarketresearch.com/reports/global-pancreatitis-market
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.
Contact Us
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – [email protected]